World Heart Corporation, together with its subsidiaries, focuses on the development and commercialization of implantable ventricular assist devices (VADs) for adults, children, and infants suffering from heart failure in the United States. The VADs are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood circulation. The company’s products in development include PediaFlow VAD, which is a small magnetically levitated axial rotary VAD intended for use in infants and children; and MiFlow VAD, a miniature maglev rotary pump, intended to provide partial to full circulatory support in adult patients in an earlier stage of heart failure, as well as for late-stage heart failure patients. World Heart Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. World Heart Corp. operates as a subsidiary of Medtronic plc.